BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33317474)

  • 1. New cut-off values for screening of trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester in pregnant women with advanced maternal age.
    Chen Y; Wang X; Li L; Lu S; Zhang Z
    BMC Pregnancy Childbirth; 2020 Dec; 20(1):776. PubMed ID: 33317474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
    Hu Z; Liu X; Li L; Jia C; Li D; Liu R
    Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18.
    Chen Y; Chen Y; Ning W; Zhang W; Li L; Wang X; Yin Y; Zhang H
    Sci Rep; 2022 Aug; 12(1):13605. PubMed ID: 35948592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and predictive value of risk models of maternal serum alpha-fetoprotein variants and fetal open neural tube defects.
    Chen Y; Wang X; Chen Y; Ning W; Chen L; Yin Y; Zhang W; Lian J; Wang H
    Exp Biol Med (Maywood); 2022 May; 247(10):822-831. PubMed ID: 35238224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].
    Qi QW; Jiang YL; Liu JT; Bian XM; Li Y; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Cai Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk: result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population.
    Chao AS; Chung CL; Wu CD; Chang SD; Cheng PJ; Lin YT; Soong YK
    Acta Obstet Gynecol Scand; 1999 May; 78(5):393-7. PubMed ID: 10326883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.
    Spencer K
    Br J Obstet Gynaecol; 1999 Dec; 106(12):1287-93. PubMed ID: 10609723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple marker screening for trisomy 21, trisomy 18 and open neural tube defects in singleton pregnancies of native Japanese pregnant women.
    Onda T; Tanaka T; Yoshida K; Nakamura Y; Kudo R; Yamamoto H; Sato A; Yanagida K; Takai Y; Uemura H; Hoshi K; Fukada Y; Miyake Y; Ohnishi M; Kaneoka T; Makino Y; Murata Y; Kanzaki T; Kanzaki H; Osaki T; Aono T; Maeda K; Ogita S; Yamamasu S; Aso T; Shimizu Y; Izutsu T; Kudo T; Okai T; Sakai M; Hashimoto T; Matsuzaki N; Kitagawa M; Sago H; Grier RE; Myrick F; Shimizu Y
    J Obstet Gynaecol Res; 2000 Dec; 26(6):441-7. PubMed ID: 11152330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Down's syndrome and neural tube defect in Croatia. A regional prospective study.
    Brajenović-Milić B; Tislarić D; Bacić J; Paravić J; Slivar AE; Kapovic M; Kosec V; Ristic S; Rajhvajn B
    Fetal Diagn Ther; 1998; 13(6):367-71. PubMed ID: 9933821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Risk Model for Predicting Fetuses with Trisomy 21 Using Alpha-Fetoprotein Variants L2 Combined with Maternal Serum Biomarkers in Early Pregnancy.
    Chen Y; Wu B; Chen Y; Ning W; Zhang H
    Reprod Sci; 2022 Apr; 29(4):1287-1295. PubMed ID: 34750768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum marker screening during the second trimester for prenatal diagnosis and predicting pregnancy outcome].
    Yang L; Zhao L; Jiang J; Liu J; Tao H; Wang J; Wu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jul; 35(7):1059-62, 1072. PubMed ID: 26198962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second trimester two-step trisomy 18 screening using maternal serum markers.
    Muller F; Sault C; Lemay C; Roussel-Mizon N; Forestier F; Frendo JL;
    Prenat Diagn; 2002 Jul; 22(7):605-8. PubMed ID: 12124697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical screening of fetal aneuploidies and neural tube defects by "double-test" in Croatia: a 10 years' experience.
    Tislarić-Medenjak D; Kosec V; Tonković-Durisević I; Zec I; Sabolović-Rudman S; Kuna K; Herman R; Ivicević-Bakulić T; Soljacić-Vranes H; Tuckar N; Muzinić D; Butorac D; Bolanca I; Kosec A; Stipoljev F
    Coll Antropol; 2011 Sep; 35(3):957-62. PubMed ID: 22053587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic accuracy of maternal serum alpha-fetoprotein variants (AFP-L2 and AFP-L3) in predicting fetal open neural tube defects and abdominal wall defects.
    Chen Y; Wang X; Lu S; Huang J; Zhang L; Hu W
    Clin Chim Acta; 2020 Aug; 507():125-131. PubMed ID: 32251652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of alpha-fetoprotein variants L2 and L3 as substitutes of alpha-fetoprotein in screening for fetal Trisomy 18.
    Chen Y; Ning W; Wang H; Chen Y; Huang J; Wen L; Hu W
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6764-6769. PubMed ID: 33980109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome.
    Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA
    Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining fetal nuchal fold thickness with second-trimester biochemistry to screen for trisomy 21.
    Borrell A; Mercade I; Casals E; Borobio V; Seres A; Soler A; Fortuny A; Cuckle H
    Ultrasound Obstet Gynecol; 2007 Dec; 30(7):941-5. PubMed ID: 18000942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.